Cost-effectiveness of imatinib versus interferon-alpha in the treatment of patients newly diagnosed with chronic myeloid leukemia, under the Brazilian public healthcare system perspective.
| Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
|---|---|
| Data(s) |
20/05/2014
20/05/2014
16/11/2006
|
| Formato |
946A-946A |
| Identificador |
http://abstracts.hematologylibrary.org/cgi/content/abstract/108/11/3314 Blood. Washington: Amer Soc Hematology, v. 108, n. 11, p. 946A-946A, 2006. 0006-4971 http://hdl.handle.net/11449/36287 WOS:000242440004362 |
| Idioma(s) |
eng |
| Publicador |
Amer Soc Hematology |
| Relação |
Blood |
| Direitos |
closedAccess |
| Tipo |
info:eu-repo/semantics/conferenceObject |
